Mast Cells and Stage IIIB Colon Cancer Survival
Author Information
Author(s): Xia Qing, Wu Xiao-Jun, Zhou Qiang, Jing-Zeng, Hou Jing-Hui, Pan Zhi-Zhong, Zhang Xiao-Shi
Primary Institution: Sun Yat-sen University Cancer Center
Hypothesis
Do mast cells contribute to the progression of stage IIIB colon cancer?
Conclusion
Mast cell counts varied by location, but none were related to 5-year survival, indicating they do not contribute to the progression of stage IIIB colon cancer.
Supporting Evidence
- Mast cell counts were higher in normal mucosa adjacent to cancer than in cancer stroma.
- Mast cell counts in lymph node metastasis were not significantly different from adjacent lymph tissue.
- Mast cell counts did not correlate with overall survival in the study population.
Takeaway
The study looked at how many mast cells were in different parts of colon cancer tissues, but found that these cells didn't help patients live longer.
Methodology
Analyzed mast cell counts in primary cancer tissues and lymph nodes from 93 stage IIIB colon cancer patients.
Potential Biases
Potential selection bias due to the small sample size.
Limitations
The sample size was small and there may be selection bias.
Participant Demographics
Patients with stage IIIB colon cancer, collected between January 1997 and July 2004.
Statistical Information
P-Value
P = 0.000
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website